Ireland's regulator of medicines, health products and medical devices for people and animals. New cancer medicines reach Ireland through the European Medicines Agency's centralised procedure.
The Health Products Regulatory Authority describes itself as regulating medicines, health products and devices for the benefit of people and animals, publishing information on authorised and withdrawn medicines and notified shortages. Under EU law, medicines with a new active substance to treat cancer must be authorised through the European Medicines Agency's centralised procedure, and the European Commission's authorisation is valid in every EU member state including Ireland. The coordinates are an approximate Dublin city point.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Health Products Regulatory Authority, including child institutions. 1 works · 0 citations · 100% open access · 100% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors 10.1016/j.ejcped.2026.100552 · open access | EJC Paediatric Oncology | 2026 | 0 |
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/